Skip to main content

Company ESG Risk Ratings

Shanghai MicroPort Endovascular MedTech Co., Ltd.

Industry Group: Healthcare

Country/Region: China

Identifier: SHG:688016

Full time employees: 908

ESG Risk Rating

Core
29.8
Medium Risk
0-10
10-20
20-30
30-40
40+

Ranking

Industry Group (1st = lowest risk)

Healthcare 409 out of 588


Universe

Global Universe 10528 out of 15080


Last Full Update: Jan 8, 2024
Last Update: Aug 31, 2024

What are the ESG Risk Ratings?

Compare Shanghai MicroPort Endovascular MedTech Co., Ltd. with other industry peers.

Industry Comparison

Company ESG Risk Rating Industry Rank
NovoCure Ltd.
27.4
 
 
 
 
 
Medium
349 out of 588
Sansure Biotech, Inc.
28.5
 
 
 
 
 
Medium
371 out of 588
Shanghai MicroPort Endovascular MedTech Co., Ltd.
29.8
 
 
 
 
 
Medium
409 out of 588
Xian Bright Laser Technologies Co., Ltd.
31.1
 
 
 
 
 
High
448 out of 588
Guangzhou Wondfo Biotech Co., Ltd.
32.8
 
 
 
 
 
High
500 out of 588

For corporate professionals interested in direct competitor insights

Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.

Our Approach to Calculating ESG Risk

The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Exposure is Medium

Low
Medium
High

Management

Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Management of ESG Material Risk is Average

Weak
Average
Strong

How do the ESG Risk Ratings work?

Controversy Rating

Highest Controversy level that has impacted Shanghai MicroPort Endovascular MedTech Co., Ltd.'s ESG Risk Rating in the last three years

Highest Controversy Level

blurred controversy level

Contributing Events

blurred controversy events

Highest Controversy Events Locations

world map blurred
Get in Touch Contact us to learn more about our Controversies Research Report

Learn how the ESG Risk Ratings are used by our clients

Corporates

Leverage Sustainalytics' ESG Risk Ratings to understand and promote your corporate ESG performance with internal and external stakeholders.

Banks and Lenders

Banks and lenders can use our ESG Risk Ratings and data as a part of a broader analysis of their clients as well as for innovative product solutions such as sustainability linked loans.

Investors

The ESG Risk Ratings can help investors to identify, understand and manage ESG risks at the security and portfolio level with the aim of improving the long-term performance of their equity and fixed income securities.